HK1018260A1 - A 1-methylcarbapenem derivative - Google Patents

A 1-methylcarbapenem derivative

Info

Publication number
HK1018260A1
HK1018260A1 HK99103162A HK99103162A HK1018260A1 HK 1018260 A1 HK1018260 A1 HK 1018260A1 HK 99103162 A HK99103162 A HK 99103162A HK 99103162 A HK99103162 A HK 99103162A HK 1018260 A1 HK1018260 A1 HK 1018260A1
Authority
HK
Hong Kong
Prior art keywords
lower alkyl
alkyl group
hydrogen atom
group
methylcarbapenem
Prior art date
Application number
HK99103162A
Other languages
English (en)
Inventor
Isao Kawamoto
Munetsugu Morimoto
Katsuya Ishikawa
Katsuhiko Kojima
Yasuo Shimoji
Satoshi Ohya
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of HK1018260A1 publication Critical patent/HK1018260A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK99103162A 1996-04-26 1999-07-22 A 1-methylcarbapenem derivative HK1018260A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10736496 1996-04-26
PCT/JP1997/001452 WO1997041123A1 (fr) 1996-04-26 1997-04-25 Derives de 1-methylcarbapeneme

Publications (1)

Publication Number Publication Date
HK1018260A1 true HK1018260A1 (en) 1999-12-17

Family

ID=14457217

Family Applications (1)

Application Number Title Priority Date Filing Date
HK99103162A HK1018260A1 (en) 1996-04-26 1999-07-22 A 1-methylcarbapenem derivative

Country Status (18)

Country Link
US (1) US5977097A (cs)
EP (1) EP0900797B1 (cs)
KR (1) KR20000064997A (cs)
CN (1) CN1093861C (cs)
AT (1) ATE222588T1 (cs)
AU (1) AU710881B2 (cs)
CA (1) CA2252723A1 (cs)
CZ (1) CZ342098A3 (cs)
DE (1) DE69714841T2 (cs)
DK (1) DK0900797T3 (cs)
ES (1) ES2180977T3 (cs)
HK (1) HK1018260A1 (cs)
HU (1) HUP9902149A3 (cs)
NO (1) NO312900B1 (cs)
NZ (1) NZ332453A (cs)
PT (1) PT900797E (cs)
RU (1) RU2162088C2 (cs)
WO (1) WO1997041123A1 (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2241092C (en) * 1995-12-21 2004-04-27 Sankyo Company, Limited 1-methylcarbapenem derivatives
AU1415500A (en) * 1998-12-07 2000-06-26 Sankyo Company Limited 1-methylcarbapenem derivatives
CA2376077A1 (en) * 1999-06-23 2000-12-28 Merck & Co., Inc. Integrin receptor antagonists
UA78524C2 (en) * 2001-09-26 2007-04-10 Merck & Co Inc A process for preparation of carbapenem compounds
WO2008026527A1 (fr) * 2006-08-28 2008-03-06 Kaneka Corporation Procédé de fabrication d'un dérivé de 3-cyanopyrrolidine ou d'un de ses sels
CN101357917B (zh) * 2007-06-22 2011-03-23 山东轩竹医药科技有限公司 含有甲酰肼基的碳青霉烯化合物
CN101367809B (zh) * 2007-06-28 2011-04-27 山东轩竹医药科技有限公司 含有巯基吡咯烷甲酰肼的培南衍生物
CN101362760B (zh) * 2007-08-07 2010-12-15 山东轩竹医药科技有限公司 1β-甲基碳代青霉烯化合物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1283906C (en) * 1983-05-09 1991-05-07 Makoto Sunagawa .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF
ATE114654T1 (de) * 1988-04-01 1994-12-15 Sankyo Co 2-(heterocyclylthio)carbapenemderivate, deren herstellung und deren verwendung als antibiotika.
JP2752143B2 (ja) * 1988-04-01 1998-05-18 三共株式会社 カルバペネム誘導体
JPH023687A (ja) * 1988-06-22 1990-01-09 Sankyo Co Ltd １−メチルカルバペネム誘導体
NO178498C (no) * 1990-02-23 1996-04-10 Sankyo Co Analogifremgangsmåte ved fremstilling av terapeutisk aktive karbapenemderivater
JPH04211083A (ja) * 1990-02-23 1992-08-03 Sankyo Co Ltd カルバペネム−３−カルボン酸誘導体
US5712267A (en) * 1991-06-04 1998-01-27 Sankyo Company,. Limited Carbapenem derivatives, their preparation and their use as antibiotics
CZ167792A3 (en) * 1991-06-04 1995-12-13 Sankyo Co 1-methylcarbapenem derivatives process of their preparation and use
CZ290002B6 (cs) * 1992-03-11 2002-05-15 Sankyo Company Limited Antimikrobiální karbapenemové deriváty, způsob výroby a farmaceutický prostředek
JP3411589B2 (ja) * 1992-05-11 2003-06-03 第一製薬株式会社 カルバペネム誘導体
JP3344662B2 (ja) * 1992-09-14 2002-11-11 三共株式会社 カルバペネム−３−カルボン酸誘導体
JPH06199860A (ja) * 1992-09-16 1994-07-19 Sankyo Co Ltd カルバペネム誘導体
JPH07228570A (ja) * 1993-12-22 1995-08-29 Sankyo Co Ltd ４−メルカプトピロリジン誘導体
JP3199300B2 (ja) * 1994-05-09 2001-08-13 三共株式会社 １−メチルカルバペネム誘導体
JPH0848667A (ja) * 1994-06-03 1996-02-20 Sankyo Co Ltd ４−メルカプトピロリジン誘導体

Also Published As

Publication number Publication date
AU710881B2 (en) 1999-09-30
NO312900B1 (no) 2002-07-15
PT900797E (pt) 2002-11-29
CN1093861C (zh) 2002-11-06
ATE222588T1 (de) 2002-09-15
CN1223655A (zh) 1999-07-21
EP0900797A1 (en) 1999-03-10
NZ332453A (en) 2000-09-29
NO984948D0 (no) 1998-10-23
WO1997041123A1 (fr) 1997-11-06
HUP9902149A3 (en) 2002-01-28
HUP9902149A2 (hu) 1999-10-28
DK0900797T3 (da) 2002-09-09
US5977097A (en) 1999-11-02
ES2180977T3 (es) 2003-02-16
KR20000064997A (ko) 2000-11-06
EP0900797A4 (en) 2000-07-19
NO984948L (no) 1998-12-21
CZ342098A3 (cs) 1999-02-17
DE69714841T2 (de) 2003-05-28
AU2407697A (en) 1997-11-19
DE69714841D1 (de) 2002-09-26
EP0900797B1 (en) 2002-08-21
RU2162088C2 (ru) 2001-01-20
CA2252723A1 (en) 1997-11-06

Similar Documents

Publication Publication Date Title
PL339771A1 (en) Substituted condensed heterocyclic compounds
EP0976748A4 (en) PYRROLIDINE DERIVATIVES HAVING PHOSPHOLIPASE A2 INHIBITING ACTIVITY
ES2110749T3 (es) Derivado de azolilamina.
EP0807630A4 (en) HETEROCYCLIC CONNECTIONS
HK1076816A1 (cs)
NZ330775A (en) 7-isoindolinyl-quinolonecarboxylic acid derivatives or salts thereof
ID24846A (id) Turunan-turunan bifenilamidina
NO982873D0 (no) 1-metylkarbapenemderivater
HK1018260A1 (en) A 1-methylcarbapenem derivative
EP1152004A4 (en) PHOSPHONIC ACID DERIVATIVES HAVING CARBOXYPEPTIDASE B INHIBITOR ACTIVITY
AU1041497A (en) Epoxysuccinamide derivative or salt thereof and medicine comprising the same
EP0921122A4 (en) NEW EPOXYSUCCINAMIDE DERIVATIVES AND ASSOCIATED SALTS
EP1020446A4 (en) NAPHTHALIMIDOBENZAMIDE DERIVATIVES
AU4279801A (en) Triazole compounds having amide linkage
EP0573659A4 (en) Pyrazolothiazolopyrimidine derivative
EP1201235A4 (en) AGENTS FOR IMPROVING THE NEUROPATHY THAT CONTAINS NITROGEN COMPOUNDS AS AN ACTIVE SUBSTANCE
PL342826A1 (en) Derivatives of cycloalkenes, their production and application

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20060425